CANCER GENETICS INC - COM (CGIX)

CUSIP: 13739U104

Q1 2014 13F Holders as of 31 Mar 2014

Type / Class
Equity / COM
Total 13F shares
2,206,554
Share change
+757,613
Total reported value
$33,294,725
Price per share
$15.09
Number of holders
32
Value change
+$11,509,697
Number of buys
15
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 13739U104?
CUSIP 13739U104 identifies CGIX - CANCER GENETICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CANCER GENETICS INC - COM (CGIX) as of Q1 2014

As of 31 Mar 2014, CANCER GENETICS INC - COM (CGIX) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,206,554 shares. The largest 10 holders included BANK OF MONTREAL /CAN/, DEERFIELD MANAGEMENT CO, Timpani Capital Management LLC, CASTLEARK MANAGEMENT LLC, VANGUARD GROUP INC, COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS, DRIEHAUS CAPITAL MANAGEMENT LLC, GRUBER & MCBAINE CAPITAL MANAGEMENT LLC, PERKINS CAPITAL MANAGEMENT INC, and Sterneck Capital Management, LLC. This page lists 32 institutional shareholders reporting positions in this security for the Q1 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.